Home » Newsletters » BioWorld Science

BioWorld Science

May 16, 1997

View Archived Issues

Company Profile: NitroMed

Airways-selective inhaled steroid for the treatment of asthma

Antiproliferative effects of PCA-4230 in vascular smooth muscle cells

Endothelin receptor blockade for airways inflammation

ABT-080 effective in animal model of lung eosinophilia

In vitro characterization of novel CysLTD1 receptor antagonist

Selectin inhibitor effective in animal model of early- and late-phase airways inflammation

Preclinical studies demonstrate antiinflammatory effects of selective PDE IV inhibitor

Tiotropium safe and effective in COPD

Anti-CD4 MAb effective in chronic, severe asthma

Briana Bio-Tech signs licensing agreement for chronic MS treatment

Cell Pathways commences phase III trial for prevention of precancerous colon polyps

LAS-31025 demonstrates good safety and efficacy in mild to moderate asthma

CoCensys enters licensing agreement with Wyeth-Ayerst for anxiety treatment

Insights on asthma research approaches

Novartis prepares gene therapy clinical trial for the treatment of brain tumors

Steroid-dependent asthma improved by treatment with FLAP inhibitor

Clinical response to PAF antagonist associated with adhesion molecule suppression

FDA clears Glaxo Wellcome's aid to smoking cessation

SR-27417A protects against inhaled PAF-induced effects in asthmatics

Abelcet earns regulatory approval in Switzerland

Campto now available in seven additional countries

NIH announces prospective grant of licenses for IL-12 antibodies

NIH announces prospective grant of exclusive license for IL-13 receptor-specific chimeric antibodies

Salix reports promising clinical results for ulcerative colitis treatment